China SXT Pharmaceuticals logo

China SXT Pharmaceuticals

SXTC | NASDAQ
Chart Builder DCF Calculator
$2.99
-$0.01 (-0.33%)
At close: Nov 16, 2026, 4:00 PM ET
$2.87
-$0.12 (-4.01%)
After-hours: Nov 16, 2026, 7:57 PM ET
-0.33%

Rating

Updated: Nov 16, 2026
29.4
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #822/1021 (Top 81%)

Key Statistics

Market Data

Market Cap $17.52K
1D Range
2.88 3.01
52W Range
1.93 24,000

Valuation (TTM)

PE 0
PB 0.00
EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company of...

Sector Healthcare
Employees 56
IPO Date Jan 4, 2019
Fiscal Year April - March

Latest News

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

26 days ago · prnewswire.com

China SXT Pharmaceuticals, Inc. Announces Share Consolidation
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right

27 days ago · prnewswire.com

China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)

1 month ago · globenewswire.com

Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering

1 month ago · prnewswire.com

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.